ATHA: Athira Pharma Company Short-Term Debt
Athira Pharma, Inc. (ATHA) is optimizing the international delivery of biomaterials for dementia therapy while maintaining high margins. An analysis of short-term borrowed resources demonstrates current liabilities, where 0.00 serves as the final level marker. Patents for neuron restoration and strict FDA oversight create a robust defensive barrier. Meanwhile, the colossal costs of drug certification render this niche inaccessible to smaller players.
Analytical breakdowns for Athira Pharma Corp (ATHA)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Athira Pharma, Inc.|ATHA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Athira Pharma, Inc.|ATHA - Company Total Debt Obligations|Debt to Book Capitalization Ratio Athira Pharma, Inc.|ATHA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Athira Pharma|Quick Liquidity Indicator athira.com
- net income and valuation multiples indicators:
Fundamental company analysis:ATHA - Athira Pharma
Assessing long-term risks requires an analysis of short-term liabilities, which measure a business's ability to settle current loans relative to US industry benchmarks. This short-term debt chart reflects the liquidity of Athira Pharma, Inc. (ATHA), which is critical amid slowing drug certification caused by geopolitical restrictions on biotechnology exports and the disruption of reagent supply chains.
Competing companies
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Current Liabilities VKTX (Viking Therapeutics, Inc.)|Amount of Current Liabilities SUPN|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Company Short-Term Loans and Borrowings DNLI|Harmony Biosciences - Company Short-Term Debts|Short-Term Debt Volume biohavenpharma.com BHVN|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Trevi Therapeutics Inc - Company Short-Term Loans and Borrowings|PRAX (Praxis Medicines) - Company Short-Term Debts|Company Short-Term Debts Anavex Life Sciences Corp|Company Current Liabilities CBLL (CeriBell, Inc.)|PRTA (Prothena Corporation plc) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Alector ALEC|ANNX (Annexon Biosciences) - Current Liabilities|Omeros Corp. - Company Short-Term Debts|Company Short-Term Loans and Borrowings NGNE (Neurogene Therapeutics)|ACIU: Company Short-Term Debts|voyagertherapeutics.com (VYGR) - Company Short-Term Debts|Company Short-Term Debt Neumora Therapeutics, Inc.|SCLX: Company Short-Term Loans and Borrowings|Company Short-Term Debt Tevogen Bio Holdings, Inc. (TVGN)|Company Current Liabilities alphacognition.com ACOG|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Debts inhibikase.com IKT|SAVA: Company Current Liabilities|Company Short-Term Loans and Borrowings ASRT (Assertio Holdings, Inc.)|COYA: Company Short-Term Debts|VTGN - Short-Term Debt Volume|Company Short-Term Debt Ovid Therapeutics Inc|Company Short-Term Indebtedness ABOS (acumenpharm.com)|Company Short-Term Debts CRVO|Company Current Liabilities alteritytherapeutics.com ATHE|Clene - Company Current Liabilities|Short-Term Debt Volume PepGen Inc (PEPG)|Jupiter Neurosciences - Company Short-Term Debts|RLMD - Company Short-Term Debts|ANVS (Annovis Bio) - Company Current Liabilities|GRCE: Amount of Current Liabilities|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|KLTO: Company Short-Term Loans and Borrowings|Company Short-Term Debts NRSN|Company Short-Term Debts revivapharma.com (RVPH)|Company Short-Term Debt MetaVia MTVA|NRXS: Company Short-Term Indebtedness|Helius Medical Technologies Inc. - Company Short-Term Debts|Short-Term Debt Passage Bio, Inc.|NEUP (bionomics.com.au) - Company Current Liabilities|minervaneurosciences.com (NERV) - Company Short-Term Debts|Company Short-Term Debt Addex Therapeutics Ltd|ALZN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX - Short-Term Debt|Company Short-Term Debts KTTA (Pasithea Therapeutics Corp.)|Company Short-Term Debts Cortigent Inc CRGT|ATXI: Company Current Liabilities|Brainstorm Cell Therapeutics Inc. - Amount of Current Liabilities|CARA: Company Short-Term Debts|Chromocell - Company Short-Term Loans and Borrowings|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Intra-Cellular (ITCI) - Short-Term Debt Volume|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|MRNS (Marinus Pharmaceuticals Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts NKGN (NKGen)|Company Short-Term Debts NeuroBo Pharma NRBO|SAGE: Company Current Liabilities|Company Short-Term Loans and Borrowings SNPX (synaptogen.com)|Trevena (TRVN) - Company Short-Term Debt|Current Liabilities VIGL (Vigil Neuroscience, Inc.)|WENA (Anew Medical, Inc.) - Company Short-Term Debts|CERE: Company Short-Term Loans and Borrowings